Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 327

1.

Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.

Corn BW, Moughan J, Knisely JP, Fox SW, Chakravarti A, Yung WK, Curran WJ Jr, Robins HI, Brachman DG, Henderson RH, Mehta MP, Movsas B.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):71-8. doi: 10.1016/j.ijrobp.2007.09.015. Epub 2007 Dec 31.

PMID:
18164829
2.

Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.

Li J, Bentzen SM, Li J, Renschler M, Mehta MP.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):64-70. doi: 10.1016/j.ijrobp.2007.09.059.

PMID:
18406884
3.

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

Knisely JP, Berkey B, Chakravarti A, Yung AW, Curran WJ Jr, Robins HI, Movsas B, Brachman DG, Henderson RH, Mehta MP.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):79-86. doi: 10.1016/j.ijrobp.2007.09.016. Epub 2007 Dec 31.

PMID:
18164847
4.

Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1388-95.

PMID:
17674975
6.

Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.

Murray KJ, Scott C, Zachariah B, Michalski JM, Demas W, Vora NL, Whitton A, Movsas B.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):59-64.

PMID:
10924972
8.

Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.

Regine WF, Schmitt FA, Scott CB, Dearth C, Patchell RA, Nichols RC Jr, Gore EM, Franklin RL 3rd, Suh JH, Mehta MP.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1346-52.

PMID:
15050309
9.

Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.

Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1069-76. doi: 10.1016/j.ijrobp.2008.05.068. Epub 2008 Oct 30.

PMID:
18977094
10.

The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.

Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):37-46. Review.

PMID:
16111570
11.

Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed.

Brown PD, Asher AL, Farace E.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1305-9. doi: 10.1016/j.ijrobp.2007.11.047. Epub 2008 Jan 30. Review.

PMID:
18234426
12.

Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.

Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG.

J Clin Oncol. 2003 Jul 1;21(13):2519-24.

PMID:
12829670
13.

Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.

Wong J, Hird A, Zhang L, Tsao M, Sinclair E, Barnes E, Danjoux C, Chow E.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1125-31. doi: 10.1016/j.ijrobp.2008.12.013. Epub 2009 Feb 21.

PMID:
19231099
14.

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF.

J Clin Oncol. 2003 Jul 1;21(13):2529-36.

PMID:
12829672
15.
16.
17.

Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03.

Corn BW, Wang M, Fox S, Michalski J, Purdy J, Simpson J, Kresl J, Curran WJ Jr, Diaz A, Mehta M, Movsas B.

J Neurooncol. 2009 Nov;95(2):247-257. doi: 10.1007/s11060-009-9923-3. Epub 2009 Jun 16.

18.

Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.

Komosinska K, Kepka L, Niwinska A, Pietrzak L, Wierzchowski M, Tyc-Szczepaniak D, Kaczmarczyk A, Bujko K.

Acta Oncol. 2010 Apr;49(3):382-8. doi: 10.3109/02841860903352942.

PMID:
20397770
19.

A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.

Butler JM Jr, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1496-501. Epub 2007 Sep 14.

PMID:
17869448
20.

Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.

Le Scodan R, Massard C, Mouret-Fourme E, Guinebretierre JM, Cohen-Solal C, De Lalande B, Moisson P, Breton-Callu C, Gardner M, Goupil A, Renody N, Floiras JL, Labib A.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):839-45. Epub 2007 Jun 4.

PMID:
17544592

Supplemental Content

Support Center